Total Foot Care Clinic, Llc | |
104 Partnership Way, Columbia, MS 39429-4502 | |
(601) 268-0400 | |
(601) 264-3150 |
Full Name | Total Foot Care Clinic, Llc |
---|---|
Type | Facility |
Speciality | Podiatrist |
Location | 104 Partnership Way, Columbia, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528440195 | NPI | - | NPPES |
09015719 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 80131 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Total Foot Care Clinic, Llc Po Box 16235, Hattiesburg, MS 39404-6235 Ph: (601) 268-0400 | Total Foot Care Clinic, Llc 104 Partnership Way, Columbia, MS 39429-4502 Ph: (601) 268-0400 |
News Archive
Cerenis Therapeutics SA, a privately held biopharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, today announced it will present the results of two clinical proof-of-concept studies for its CER-627 program (niacin/aspirin combinations) at the 78th European Atherosclerosis Society Congress on June 20-23 in Hamburg, Germany.
Ryan & Maniskas, LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of BioSphere Medical, Inc. in connection with their actions in causing BioSphere Medical to enter into a merger agreement with Merit Medical System, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co.
Celldex Therapeutics, Inc. announced today the successful completion of its acquisition of CuraGen Corporation (Nasdaq: CRGN) pursuant to the previously disclosed Agreement and Plan of Merger, dated as of May 28, 2009, by and among CuraGen, Celldex and Celldex's merger subsidiary, Cottrell Merger Sub, Inc.
University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.
Jamila K. Stockman, PhD, MPH, assistant professor of medicine and global public health at the University of California, San Diego School of Medicine has been selected to receive the Linda E. Saltzman New Investigator Award.
› Verified 6 days ago